During EMS2018 sponsors and exhibitors will be able to host a symposia or a workshop as part of the EMS2018 program. You can read more about these below.
If you are a sponsor or exhibitor you can download the Exhibition & Sponsorship Prospectus for more information or contact:
Exhibition and Sponsorship Organiser
Crone & Co
DK-1620 Copenhagen V
Falcks session on Prehospital infection control: Why, what and how?
The aim of the session is to underline the importance of infection control during EMS care and treatment. Three different but coherent presentations will take the listeners through essentials on why, what and how to prioritize hygiene in the EMS. Presentation duration is 20 minutes each, with 5-10 minutes for questions in-between sessions.
Presentation 1: Why is hygiene important?
Professor Hans Jørn Kolmos will highlight hygiene as a patient safety issue, in regards to the extent of healthcare associated infections in Europe, and the relation between poor hygiene and infection risk.
Presentation 2: What do we know about prehospital hygiene?
PhD student Heidi Storm Vikke will present STATE OF THE ART on prehospital hygiene, and focus on current evidence on microbial contamination, cleaning interventions and hygiene compliance.
Presentation 3: How to secure a high quality hygiene in the EMS
This presentation by German researcher Jens Parey highlights essentials on how to secure high quality hygiene in an EMS organization on a daily basis. The German EMS operator GARD will introduce the listeners to how to plan and conduct hygiene control, and how the results can be used for improvement purposes.
The session will take place as part of the EMS2018 scientific program on Tuesday the 17th April, 10.30-11.45. The session will be chaired by Rune Andersen, Bid Excellence Manager from Falck Denmark.
Mundipharma Lunch Symposium: Advancing trauma pain analgesia: illustrating the benefits and value of inhaled methoxyflurane
Managing trauma pain in the pre-hospital and emergency setting remains a challenge despite recent advances in the field. The goal of this symposium is to explore how inhaled methoxyflurane can bridge the analgesic gap between initial injury, during extraction from the trauma scene and subsequent interventions and medications.
Through presentation and case studies, our faculty of international clinicians will give an overview of Penthrox® (methoxyflurane) data and then illustrate the benefits and value of its use in the real world through interactive case study discussion.
Time for fast, effective analgesia
Dr Poul Kongstad will lead us through the rationale for methoxyflurane and an overview of the data supporting its use, both from clinical studies and more than 40 years of experience in Australia.
Inhaled methoxyflurane in clinical practice – the missing link?
Through dynamic, interactive case studies Drs Jason van der Velde, Maxime Maignan and Sergio Garcia will explore how Penthrox is being used in the real world across Europe. Cases will explore the role of Penthrox in effective pain management in trauma pain encountered in complicated environments or difficult terrain, in patients who need fast extraction to hospital or interventions in the field and the value that Penthrox can bring in these situations.
This symposium has been arranged by Mundipharma International Limited and will contain discussion of Mundipharma products.
Penthrox is approved following the EC decentralised procedure in 24 European countries, and has corresponding local marketing authorisations in many of these countries, including Denmark. A full list of countries where Penthrox is locally approved is available upon request from this stand/at this symposium.
Penthrox is expected to become available in Denmark in 2018.
The session will take place as part of the EMS2018 scientific program on Tuesday the 17th April, 12.00-13.00 at ‘Pjerrot’.